Hofseth Biocare Financials
| HBC Stock | NOK 3.15 0.01 0.32% |
Hofseth |
Understanding current and past Hofseth Biocare Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hofseth Biocare's financial statements are interrelated, with each one affecting the others. For example, an increase in Hofseth Biocare's assets may result in an increase in income on the income statement.
Hofseth Biocare Stock Summary
Hofseth Biocare competes with PCI Biotech, Bergenbio ASA, and Grieg Seafood. Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people.| Foreign Associate | Canada |
| Instrument | Norway Stock View All |
| Exchange | Oslo Stock Exchange |
| ISIN | NO0010598683 |
| Business Address | Kipervikgata 13, lesund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.hofsethbiocare.no |
| Phone | 47 73 10 22 00 |
| Currency | NOK - Kroner |
You should never invest in Hofseth Biocare without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Hofseth Stock, because this is throwing your money away. Analyzing the key information contained in Hofseth Biocare's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Hofseth Biocare Key Financial Ratios
There are many critical financial ratios that Hofseth Biocare's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Hofseth Biocare ASA reports annually and quarterly.| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 | |||
| Beta | 0.54 | |||
| Z Score | 4.8 |
Hofseth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hofseth Biocare's current stock value. Our valuation model uses many indicators to compare Hofseth Biocare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hofseth Biocare competition to find correlations between indicators driving Hofseth Biocare's intrinsic value. More Info.Hofseth Biocare ASA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hofseth Biocare's earnings, one of the primary drivers of an investment's value.Hofseth Biocare ASA Systematic Risk
Hofseth Biocare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hofseth Biocare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Hofseth Biocare ASA correlated with the market. If Beta is less than 0 Hofseth Biocare generally moves in the opposite direction as compared to the market. If Hofseth Biocare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hofseth Biocare ASA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hofseth Biocare is generally in the same direction as the market. If Beta > 1 Hofseth Biocare moves generally in the same direction as, but more than the movement of the benchmark.
Hofseth Biocare January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hofseth Biocare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hofseth Biocare ASA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hofseth Biocare ASA based on widely used predictive technical indicators. In general, we focus on analyzing Hofseth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hofseth Biocare's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.92 | |||
| Information Ratio | 0.1661 | |||
| Maximum Drawdown | 46.04 | |||
| Value At Risk | (7.50) | |||
| Potential Upside | 12.78 |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.